These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 1367121)
1. Methylation state of the human HLA-DR alpha gene in transgenic mice. Feriotto G; Pozzi L; Deledda F; Barbieri R; Piva R; Nastruzzi C; Ciucci A; Natali PG; Giacomini P; Gambari R Cytotechnology; 1991; 5 Suppl 1():55-6. PubMed ID: 1367121 [No Abstract] [Full Text] [Related]
2. [Functional expression of xenogenic mixed isotype molecule, DR alpha E beta, in transgenic mice with HLA-DRA gene on X chromosome]. Fukui Y Fukuoka Igaku Zasshi; 1992 Feb; 83(2):80-90. PubMed ID: 1534306 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mice mimic the methylation pattern of the human HLA-DR alpha gene. Feriotto G; Pozzi L; Piva R; Deledda F; Barbieri R; Nastruzzi C; Ciucci A; Natali PG; Giacomini P; Gambari R Biochem Biophys Res Commun; 1991 Mar; 175(2):459-66. PubMed ID: 2018494 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression. Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957 [TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of HLA-DRalpha, DRB1*0401 transgenic mice model]. Deng J; Wu H; You X; Feng Q; Li F; Zhu Y; Lu G Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):360-3. PubMed ID: 10581343 [TBL] [Abstract][Full Text] [Related]
6. Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. Baxevanis CN; Thanos D; Reclos GJ; Anastasopoulos E; Tsokos GC; Papamatheakis J; Papamichail M J Immunol; 1992 Apr; 148(7):1979-84. PubMed ID: 1545115 [TBL] [Abstract][Full Text] [Related]
7. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice. Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213 [TBL] [Abstract][Full Text] [Related]
8. Methylation state of the human HLA-DRA gene in T-lymphocytes and B-lymphocytes of transgenic mice. Lack of methylation at one 5'-GCGC site is not required for gene expression. Feriotto G; Pozzi L; Ciucci A; Camarda G; Mischiati C; D'Agnano I; Gambari R; Giacomini P Eur J Biochem; 1993 Dec; 218(2):485-92. PubMed ID: 8269938 [TBL] [Abstract][Full Text] [Related]
9. Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control. Rosa FM; Fellous M J Immunol; 1988 Mar; 140(5):1660-4. PubMed ID: 3126233 [TBL] [Abstract][Full Text] [Related]
10. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia. Tobe H; Ruether BA; Jerry LM; Tamaoki T Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264 [TBL] [Abstract][Full Text] [Related]
11. "In vitro" methylation of GCGC sites of the human HLA-DR alpha gene by E. coli HhaI methylase: effects of chromatin proteins. Mischiati C; Barbieri R; Nastruzzi C; Orlando P; Gambari R Boll Soc Ital Biol Sper; 1988 Jun; 64(6):489-93. PubMed ID: 3056460 [No Abstract] [Full Text] [Related]
12. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. Pan S; Trejo T; Hansen J; Smart M; David CS J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354 [TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells. Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133 [TBL] [Abstract][Full Text] [Related]
14. HLA class II transgenic mice mimic human inflammatory diseases. Mangalam AK; Rajagopalan G; Taneja V; David CS Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769 [TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in humanized transgenic mice. Koehm S; Slavin RG; Hutcheson PS; Trejo T; David CS; Bellone CJ J Allergy Clin Immunol; 2007 Sep; 120(3):570-7. PubMed ID: 17561243 [TBL] [Abstract][Full Text] [Related]
16. A binding protein to the DNase I hypersensitive site II in HLA-DR alpha gene was identified as NF90. Sakamoto S; Morisawa K; Ota K; Nie J; Taniguchi T Biochemistry; 1999 Mar; 38(11):3355-61. PubMed ID: 10079079 [TBL] [Abstract][Full Text] [Related]
17. Expression of HLA-DR by a human monocyte cell line is under transcriptional control. Peterlin BM; Gonwa TA; Stobo JD J Mol Cell Immunol; 1984; 1(3):191-200. PubMed ID: 6443852 [TBL] [Abstract][Full Text] [Related]
18. HLA transgenic mice as models of human autoimmune diseases. Das P; Abraham R; David C Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. Pfizenmaier K; Scheurich P; Schlüter C; Krönke M J Immunol; 1987 Feb; 138(3):975-80. PubMed ID: 2433337 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements. Reimold AM; Kara CJ; Rooney JW; Glimcher LH J Immunol; 1993 Oct; 151(8):4173-82. PubMed ID: 8409394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]